| Literature DB >> 12019203 |
Brian T Ethell1, Sean Ekins, Jibo Wang, Brian Burchell.
Abstract
UGT1A6 and UGT1A9 have both been demonstrated to rapidly glucuronidate simple phenolic compounds. A series of simple phenols were selected and screened with both isoforms and then used as model substrates for the generation of V(max) and K(m) values. UGT1A6 showed a more restricted acceptance of phenolic substrates compared with UGT1A9. However, the affinity of UGT1A6 for these compounds exhibited higher K(m) values than UGT1A9, although rates of turnover were similar. Molecular surface-weighted holistic invariant molecular descriptors were generated for each substrate and used to produce the first quantitative structure activity relationship models generated for expressed human UGTs. Models relating log of the K(m) value to the generated descriptors correlated well with the experimental data r(2) value of 0.996 for UGT1A6 and r(2) value of 0.83 for UGT1A9. Cross validation by a leave-one-out method also showed good predictive capability within the subset with a q(2) value of 0.98 for UGT1A6 and q(2) value of 0.73 for UGT1A9. Empirically, UGT1A6 V(max) decreased as the 4-substituent increased in size, and a trend was observed when UGT1A6 V(max) was plotted against molecular volume. The larger UGT1A6 substrates were typified by low activity and lower K(m) values than their smaller counterparts. Extrapolating from this, it was demonstrated that phenols with large 4-substituents, which were not UGT1A6 substrates, could inhibit 4-ethylphenol glucuronidation. The K(m) values for UGT1A9 showed a similar relationship to UGT1A6 but with much lower K(m) values and greater variability in range of this value.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12019203 DOI: 10.1124/dmd.30.6.734
Source DB: PubMed Journal: Drug Metab Dispos ISSN: 0090-9556 Impact factor: 3.922